medroxyprogesterone acetate has been researched along with Diabetes Mellitus, Type 2 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canalis, E; Mirza, F | 1 |
| Brinton, RD; Craft, S; Espeland, MA; Hugenschmidt, C; Jackson, RD; Johnson, KC; Manson, JE; Padula, CB; Resnick, SM; Vaughan, L; Weitlauf, J; Yaffe, K | 1 |
| Lawrenson, R; Mulnier, H; Nicholls, P; Shawe, J | 1 |
| Allum, AR; de Jong, SA; Jones, SD; Manning, PJ; Sutherland, WH | 1 |
| Curtis, KM; Kahn, HS; Marchbanks, PA | 1 |
| Barrett-Connor, E; Bittner, V; Cauley, JA; Grady, D; Herrington, D; Kanaya, AM; Lin, F; Vittinghoff, E | 1 |
| Mehta, A; Orija, IB | 1 |
| Buchanan, TA; Kawakubo, M; Kjos, SL; Xiang, AH | 1 |
| Arranto, AJ; Keinänen, K; Kerola, T; Saarni, HU; Sotaniemi, EA; Stengård, JH; Sutinen, S | 1 |
| Andersson, B; Mattsson, LA | 1 |
| Diamond, T; Howes, LG; Manwaring, P; Morfis, L | 1 |
| Diab, KM; Zaki, MM | 1 |
| Hirata, K; Ishida, T; Murao, S; Takahara, J | 1 |
| Campbell, L; Hayward, CS; Kelly, RP; Samaras, K | 1 |
| Davis, RW | 1 |
2 review(s) available for medroxyprogesterone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
Topics: Acromegaly; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autoimmune Diseases; Celiac Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucocorticoids; Gonadotropin-Releasing Hormone; Human Growth Hormone; Humans; Hyperparathyroidism, Primary; Hyperthyroidism; Hypogonadism; Inflammatory Bowel Diseases; Medroxyprogesterone Acetate; Multiple Myeloma; Osteoporosis; Thyroxine | 2015 |
Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.
Topics: Contraceptive Agents, Female; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Incidence; Insulin; Levonorgestrel; Medroxyprogesterone Acetate; Risk Factors | 2003 |
6 trial(s) available for medroxyprogesterone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
Topics: Aged; Aged, 80 and over; Brain; Cognition; Cognition Disorders; Dementia; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Glucose; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2015 |
Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with Type 2 diabetes.
Topics: Administration, Oral; Aged; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Leukocyte Count; Linear Models; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Statistics, Nonparametric; Vascular Cell Adhesion Molecule-1 | 2002 |
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Risk Factors | 2003 |
The effects of hormone replacement therapy on plasma lipids in type II diabetes.
Topics: Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estrogens, Conjugated (USP); Female; Glucose; Hormone Replacement Therapy; Humans; Insulin; Lipid Metabolism; Lipids; Medroxyprogesterone Acetate; Middle Aged; Triglycerides | 2000 |
Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.
Topics: Adult; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Norpregnenes; Prospective Studies | 2000 |
Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cross-Over Studies; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Manometry; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies | 2001 |
8 other study(ies) available for medroxyprogesterone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Use of hormonal contraceptive methods by women with diabetes.
Topics: Adolescent; Adult; Case-Control Studies; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Databases as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Medical Records Systems, Computerized; Medroxyprogesterone Acetate; Practice Patterns, Physicians'; Progesterone Congeners; United Kingdom; Women's Health; Young Adult | 2008 |
Summaries for patients. Postmenopausal hormone therapy and blood sugar.
Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Risk Factors | 2003 |
Hormone replacement therapy: current controversies.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners | 2003 |
Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus.
Topics: Adult; Cohort Studies; Contraceptives, Oral, Combined; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Hispanic or Latino; Humans; Medroxyprogesterone Acetate; Pregnancy; Risk; Triglycerides | 2006 |
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.
Topics: Aged; Antipyrine; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Enzyme Induction; Female; Glipizide; Glucose-6-Phosphatase; Humans; Liver; Liver Glycogen; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Microsomes, Liver; Middle Aged; Phenobarbital | 1984 |
The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Glucose Tolerance Test; Homeostasis; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners | 1999 |
Troglitazone in progesterone derivative-induced impairment of glucose tolerance.
Topics: Aged; Antineoplastic Agents, Hormonal; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Medroxyprogesterone Acetate; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Woman with Down syndrome requires contraception.
Topics: Adult; Contraception; Diabetes Mellitus, Type 2; Down Syndrome; Female; Humans; Medroxyprogesterone Acetate; Risk Factors; Sex Education | 1992 |